Clinical trial
Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer
NCT02419807 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer
- Lead sponsor
- Case Comprehensive Cancer Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 17, 2015
- Completion date
- February 28, 2019
- Enrollment
- 102 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
stage i breast cancer, stage ii breast cancer